Defective Ribosome Biogenesis Drives Tubular Senescence and Renal Fibrosis via IRBC–p53 Activation
- 1Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
Abstract
Impaired ribosome biogenesis (RiBi) triggers the impaired ribosome biogenesis checkpoint (IRBC), a nucleolar stress pathway that stabilizes p53 and induces cellular senescence. Whether RiBi dysfunction directly drives renal interstitial fibrosis (RIF) remains unknown. Here, we combined human IgA nephropathy biopsies, murine fibrosis models, and cultured proximal tubular epithelial cells treated with the RNA polymerase I inhibitor CX5461, the p53 inhibitor pifithrin-α, siRNA-mediated POLR1A knockdown, and the DNA-damaging agent etoposide to dissect the RiBi–IRBC–p53–senescence axis. We identified defective rDNA transcription in the proximal tubules of fibrotic human kidneys and in experimental fibrosis models. Pharmacological RiBi inhibition with CX5461 induced RIF prior to functional decline. Mechanistically, RiBi impairment promoted RPL5/RPL11 binding to HDM2, stabilized p53, upregulated p21, and induced G2/M arrest, which was rescued by pifithrin-α. Genetic silencing of POLR1A recapitulated IRBC activation and senescence without causing DNA damage. Time-course analysis showed only marginal γ-H2AX elevation by CX5461 versus robust induction by etoposide. Importantly, etoposide-induced DNA damage failed to enhance RPL5/RPL11-HDM2 binding, suggesting that IRBC activation is not a general consequence of the DNA damage response. Collectively, impaired RiBi drives RIF mainly through the IRBC–p53–senescence axis under our experimental conditions, providing a mechanistic framework for understanding organ toxicities associated with RNA Pol I inhibition.
Related
- Targeting ribosome biogenesis sensitizes PARPi-resistant triple-negative breast cancer
- AICAR attenuates senescence-associated phenotypic remodeling of liver sinusoidal endothelial cells via the AMPK–SIRT1/p53 axis in CCl₄-induced liver fibrosis
- Perturbation of 60 S Ribosomal Biogenesis Results in Ribosomal Protein L5- and L11-dependent p53 Activation
- LKB1 promotes lung adenocarcinoma cell senescence by suppressing the O-GlcNAc glycosylation-mediated activation of telomerase
- Codonopsis tangshen Attenuates Age-Related Pulmonary Fibrosis Through Senescence and Gut–Lung Axis Modulation
BibTeX
@article{song2026defective,
title = {{Defective Ribosome Biogenesis Drives Tubular Senescence and Renal Fibrosis via IRBC–p53 Activation}},
author = {Kaixin Song and Hua Su},
journal = {Cells},
year = {2026},
month = oct,
doi = {10.3390/cells15201888},
url = {https://www.mdpi.com/2073-4409/15/20/1888},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Defective Ribosome Biogenesis Drives Tubular Senescence and Renal Fibrosis via IRBC–p53 Activation
AU - Kaixin Song
AU - Hua Su
PY - 2026
DA - 2026/10/16
JO - Cells
DO - 10.3390/cells15201888
UR - https://www.mdpi.com/2073-4409/15/20/1888
AB - Impaired ribosome biogenesis (RiBi) triggers the impaired ribosome biogenesis checkpoint (IRBC), a nucleolar stress pathway that stabilizes p53 and induces cellular senescence. Whether RiBi dysfunction directly drives renal interstitial fibrosis (RIF) remains unknown. Here, we combined human IgA nephropathy biopsies, murine fibrosis models, and cultured proximal tubular epithelial cells treated with the RNA polymerase I inhibitor CX5461, the p53 inhibitor pifithrin-α, siRNA-mediated POLR1A knockdown, and the DNA-damaging agent etoposide to dissect the RiBi–IRBC–p53–senescence axis. We identified defective rDNA transcription in the proximal tubules of fibrotic human kidneys and in experimental fibrosis models. Pharmacological RiBi inhibition with CX5461 induced RIF prior to functional decline. Mechanistically, RiBi impairment promoted RPL5/RPL11 binding to HDM2, stabilized p53, upregulated p21, and induced G2/M arrest, which was rescued by pifithrin-α. Genetic silencing of POLR1A recapitulated IRBC activation and senescence without causing DNA damage. Time-course analysis showed only marginal γ-H2AX elevation by CX5461 versus robust induction by etoposide. Importantly, etoposide-induced DNA damage failed to enhance RPL5/RPL11-HDM2 binding, suggesting that IRBC activation is not a general consequence of the DNA damage response. Collectively, impaired RiBi drives RIF mainly through the IRBC–p53–senescence axis under our experimental conditions, providing a mechanistic framework for understanding organ toxicities associated with RNA Pol I inhibition.
SN - 2073-4409
ER -